- Home
- ABVC vs NEPH Comparison
ABVC vs NEPH Comparison
Compare ABVC & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- NEPH
- Stock Information
- Founded
- ABVC 2015
- NEPH 1997
- Country
- ABVC United States
- NEPH United States
- Employees
- ABVC N/A
- NEPH N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- NEPH Medical/Dental Instruments
- Sector
- ABVC Health Care
- NEPH Health Care
- Exchange
- ABVC Nasdaq
- NEPH Nasdaq
- Market Cap
- ABVC 16.7M
- NEPH 16.8M
- IPO Year
- ABVC N/A
- NEPH 2004
- Fundamental
- Price
- ABVC $0.98
- NEPH $2.01
- Analyst Decision
- ABVC
- NEPH Buy
- Analyst Count
- ABVC 0
- NEPH 1
- Target Price
- ABVC N/A
- NEPH $5.00
- AVG Volume (30 Days)
- ABVC 655.9K
- NEPH 11.3K
- Earning Date
- ABVC 04-15-2025
- NEPH 05-08-2025
- Dividend Yield
- ABVC N/A
- NEPH N/A
- EPS Growth
- ABVC N/A
- NEPH N/A
- EPS
- ABVC N/A
- NEPH 0.01
- Revenue
- ABVC $509,588.00
- NEPH $14,162,000.00
- Revenue This Year
- ABVC $735.18
- NEPH $9.23
- Revenue Next Year
- ABVC N/A
- NEPH $12.99
- P/E Ratio
- ABVC N/A
- NEPH $285.92
- Revenue Growth
- ABVC 234.31
- NEPH N/A
- 52 Week Low
- ABVC $0.40
- NEPH $1.36
- 52 Week High
- ABVC $1.73
- NEPH $2.55
- Technical
- Relative Strength Index (RSI)
- ABVC 56.38
- NEPH 59.37
- Support Level
- ABVC $0.81
- NEPH $1.86
- Resistance Level
- ABVC $1.00
- NEPH $2.05
- Average True Range (ATR)
- ABVC 0.16
- NEPH 0.10
- MACD
- ABVC -0.01
- NEPH -0.01
- Stochastic Oscillator
- ABVC 39.92
- NEPH 87.02
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.